Dongkook Pharmaceutical’s dermocosmetic brand Centellian24 has released an updated version of its flagship product, Madeca Cream, under the name “Madeca Cream Aging Focus,” extending one of Korea’s most recognizable centella-asiatica-based skincare products into an anti-aging-specific formulation aimed at an older demographic than the brand’s original barrier-repair-focused customer base.
The original Madeca Cream built its reputation on madecassoside, a centella asiatica-derived compound long used in Korean dermocosmetics for its soothing and skin-barrier-repair properties, and became one of the more commercially successful “cica” (centella-focused) products in a Korean skincare market that has embraced centella-based formulations broadly since the ingredient’s mainstream popularization roughly a decade ago.
The Aging Focus extension reflects a common strategy among established Korean dermocosmetic brands: rather than launching an entirely new product line to address anti-aging demand, brands increasingly extend already-trusted hero products into adjacent formulations, leveraging existing consumer trust in the base ingredient and brand rather than building anti-aging credibility from scratch with an unfamiliar new product name.
Dongkook Pharmaceutical’s continued investment in the Centellian24 brand reflects the broader strength of Korea’s dermocosmetic (pharmacy-adjacent skincare) category, which has grown steadily as Korean consumers increasingly favor skincare brands with pharmaceutical-company backing and clinical-sounding formulation claims over purely cosmetic-industry branding, particularly for products targeting sensitive or aging skin concerns.
The new formulation arrives amid a broader wave of ingredient-focused product launches across Korea’s skincare industry in 2026, with brands across price tiers racing to update flagship products with more targeted, demographic-specific formulations rather than relying on original hero-product formulas indefinitely.
Source: Centellian24 “Madeca Cream Aging Focus” product launch, Dongkook Pharmaceutical, Korean beauty trade press, 2026.
